ZA200904281B - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders - Google Patents
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disordersInfo
- Publication number
- ZA200904281B ZA200904281B ZA200904281A ZA200904281A ZA200904281B ZA 200904281 B ZA200904281 B ZA 200904281B ZA 200904281 A ZA200904281 A ZA 200904281A ZA 200904281 A ZA200904281 A ZA 200904281A ZA 200904281 B ZA200904281 B ZA 200904281B
- Authority
- ZA
- South Africa
- Prior art keywords
- diabetes
- treatment
- receptor agonists
- metabolic disorders
- heterocyclic
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87790306P | 2006-12-28 | 2006-12-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200904281B true ZA200904281B (en) | 2010-08-25 |
Family
ID=40261614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200904281A ZA200904281B (en) | 2006-12-28 | 2007-12-27 | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN101616586B (es) |
AR (1) | AR064702A1 (es) |
CL (1) | CL2007003841A1 (es) |
TW (1) | TWI414523B (es) |
ZA (1) | ZA200904281B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7638541B2 (en) | 2006-12-28 | 2009-12-29 | Metabolex Inc. | 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
US20090270404A1 (en) * | 2008-03-31 | 2009-10-29 | Metabolex, Inc. | Oxymethylene aryl compounds and uses thereof |
CN102666553B (zh) | 2009-10-01 | 2015-05-06 | 赛马拜制药公司 | 取代的四唑-1-基-苯氧基甲基-噻唑-2-基-哌啶基-嘧啶盐 |
JP5960683B2 (ja) * | 2010-04-28 | 2016-08-02 | バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH | 殺真菌剤としてのケトヘテロアリールピペリジンおよび−ピペラジン誘導体 |
BR112012032248A2 (pt) * | 2010-06-23 | 2016-09-13 | Metabolex Inc | composições de 5-etil-2-{4-[-4(-4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina |
CN103467398B (zh) * | 2013-09-03 | 2015-01-21 | 浙江医药高等专科学校 | ***酰胺类化合物、其制备方法和其抗糖尿病用途 |
WO2015101957A2 (en) * | 2014-01-06 | 2015-07-09 | Rhizen Pharmaceuticals Sa | Novel glutaminase inhibitors |
US10292983B2 (en) | 2016-08-03 | 2019-05-21 | Cymabay Therapeutics, Inc. | Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions |
CN111072652B (zh) * | 2018-10-19 | 2023-05-23 | 暨南大学 | 用于治疗糖尿病和/或相关病症的化合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1829718A (zh) * | 2003-07-14 | 2006-09-06 | 艾尼纳制药公司 | 作为新陈代谢调节剂的稠合芳基和杂芳基衍生物以及预防和治疗与其相关的病症 |
JP4958560B2 (ja) * | 2003-12-24 | 2012-06-20 | プロシディオン・リミテッド | Gpcr受容体作動薬としてのヘテロ環誘導体 |
-
2007
- 2007-12-27 CL CL2007003841A patent/CL2007003841A1/es unknown
- 2007-12-27 TW TW96150669A patent/TWI414523B/zh active
- 2007-12-27 ZA ZA200904281A patent/ZA200904281B/xx unknown
- 2007-12-27 CN CN200780048023.8A patent/CN101616586B/zh active Active
- 2007-12-28 AR ARP070105977 patent/AR064702A1/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CN101616586B (zh) | 2014-08-13 |
CN101616586A (zh) | 2009-12-30 |
TWI414523B (zh) | 2013-11-11 |
TW200833688A (en) | 2008-08-16 |
AR064702A1 (es) | 2009-04-22 |
CL2007003841A1 (es) | 2008-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0814294A2 (pt) | Agonistas de receptor heterocíclico ligado a n para o tratamento do diabetes e de desordens metabólicas. | |
ZA200904281B (en) | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | |
WO2007109135A3 (en) | Neuromedin u receptor agonists and uses thereof | |
ZA200806510B (en) | Heterobicyclic sulfonamide derivatives for the treatment of diabetes | |
EP1976377A4 (en) | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | |
ZA201008807B (en) | Gip-based mixed agonists for treatment of metabolic disorders and obesity | |
EP1983972A4 (en) | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | |
ZA200900734B (en) | Combination treatment for metabolic disorders | |
ZA200808963B (en) | Compounds for the treatment of metabolic disorders | |
EP1981526A4 (en) | ADIPONECTIN FOR THE TREATMENT OF VARIOUS DISORDERS | |
IL205381A0 (en) | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | |
EP2217073A4 (en) | METHOD FOR THE TREATMENT OF METABOLISM DISORDER AND DEPRESSION WITH DOPAMINE RECEPTOR AGONISTS | |
IL193800A0 (en) | Endothelin and endothelin receptor agonists in the treatment of metabolic diseases | |
IL194189A0 (en) | Combination treatment of metabolic disorders | |
IL192852A0 (en) | Compounds for the treatment of metabolic disorders | |
EP2051732A4 (en) | DIAGNOSIS AND TREATMENT OF METABOLIC DISORDERS AND METHODS THEREFOR | |
HK1098155A1 (en) | Nicotinic receptor agonists for the treatment of inflammatory diseases | |
IL197695A0 (en) | 3-amino-pyridine derivatives for the treatment of metabolic disorders | |
IL201119A0 (en) | Methods and compositions of derivatives of probucol for the treatment of diabetes | |
IL192851A0 (en) | Compounds for the treatment of metabolic disorders | |
IL195392A0 (en) | Compounds for the treatment of metabolic disorders | |
IL195920A0 (en) | 3-(1h-indol-3-ydindan-1-ylamine derivatives for the treatment of depression and anxiety | |
IL192982A0 (en) | Compounds for the treatment of metabolic disorders |